NSEGeneral Updates6d ago · 25 Aug 2026, 11:29 pm

General Updates

Gujarat Themis Biosyn Limited · GUJTHEM

✦ AI SummaryFundraise

Gujarat Themis Biosyn Limited has informed the Exchange about General Updates - Outcome of Board meeting relating to QIP Issue. The company has approved the preliminary placement document, authorized the opening of the proposed Issue of Equity Shares to eligible QIBs, and approved the floor price for the QIP.

Analysis Scores

Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk3/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Gujarat Themis Biosyn Limited has informed the Exchange about General Updates - Outcome of Board meeting relating to QIP Issue.

Attachments (1)

📄

GUJARATTHEMIS_25082026232939_SEOutcome25082026.pdf

pdf

Download →
View document text
GUJARAT THEMIS BIOSYN LIMITED CIN: L24230GJ1981PLC004878 REGD. OFFICE & FACTORY: 69/C GIDC INDUSTRIAL ESTATE, VAPI – 396 195, DIST. VALSAD, GUJARAT, INDIA TE: 0260-2430027 / 2400639 E-mail:hrm@gtbl.in.net 25th August, 2026 The Manager The General Manager Listing Department Department of Corporate Services National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block-G Phiroze Jeejeebhoy Towers, Dalal Street Bandra Kurla Complex Mumbai - 400 001 Bandra East Mumbai - 400 051 Symbol: GUJTHEM Scrip Code: 506879 Dear Sir/Madam, Re: Qualified institutions placement (“QIP or “Issue”) of equity shares of face value of ₹ 1 each (the “Equity Shares”) to qualified institutional buyers (the “QIBs”) Sub: Outcome of the meeting of the Board of Directors We wish to inform you that pursuant to the approval of the board of directors of the Company at its meeting held on 25th August, 2026 and approval of the shareholders of the Company by way of a special resolution passed on 22nd August, 2026, the Board of Directors of the Company, in its meeting held today i.e. 25th August, 2026, has inter alia considered and approved the following: (i) approval and adoption of the preliminary placement document dated 25th August, 2026, and the draft of application form, in connection with the QIP; (ii) authorizing the opening of the proposed Issue of such number of Equity Shares to eligible QIBs through a qualified institutions placement under Chapter VI of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (“SEBI ICDR Regulations”) and Section 42 and 62 (1) (c) of the Companies Act, 2013, read with Rule 14 of the Companies (Prospectus and Allotment of Securities) Rules, 2014, each as amended today, i.e. on 25th August, 2026; and (iii) approved the floor price for the QIP, as prescribed under SEBI ICDR Regulations. We further wish to inform you that the ‘Relevant Date’ for the purpose of the QIP, in terms of the SEBI ICDR Regulations is 25th August, 2026 and accordingly the floor price in respect of the QIP, based on the pricing formula as prescribed under Regulation 176(1) of the SEBI ICDR Regulations is ₹ 372.57 per Equity Share. Pursuant to Regulation 176(1) of the SEBI ICDR Regulations and special resolution of the Shareholders dated 22nd August, 2026, the Company MUMBAI OFFICE: Themis House, 11/12 Udyog Nagar, S.V Road, Goregaon (West), Mumbai – 400 104 Tel: 91-22-67607080 / 28757836 Fax: 28746621 / 67607019 E-mail: gtblmumbai@gtbl.in Website Address: www.gtbl.in GUJARAT THEMIS BIOSYN LIMITED CIN: L24230GJ1981PLC004878 REGD. OFFICE & FACTORY: 69/C GIDC INDUSTRIAL ESTATE, VAPI – 396 195, DIST. VALSAD, GUJARAT, INDIA TE: 0260-2430027 / 2400639 E-mail:hrm@gtbl.in.net may, at its discretion, offer a discount of not more than 5% (five percent) on the floor price so calculated for the QIP. The Board meeting commenced at 10:15 p.m. and the meeting was concluded at 11:15 p.m. In relation to the QIP, we are filing the preliminary placement document dated 25th August, 2026 with your office. Copy of this intimation is also being made available on the website of the Company at www.gtbl.in. Further, as per Company’s Code of Conduct for Regulating, Monitoring and Reporting to regulate, monitor and report trading by Designated Persons (“Code”), the trading window for dealing in the securities of the Company is closed from 25th August, 2026 till 48 hours after determination of Issue price for all ‘Designated Persons’ as defined in the Code. We request you to take the above on record pursuant to compliance under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended. Thanking you, Yours faithfully For Gujarat Themis Biosyn Limited Vineet Gawankar Company Secretary & Compliance Officer MUMBAI OFFICE: Themis House, 11/12 Udyog Nagar, S.V Road, Goregaon (West), Mumbai – 400 104 Tel: 91-22-67607080 / 28757836 Fax: 28746621 / 67607019 E-mail: gtblmumbai@gtbl.in Website Address: www.gtbl.in